Invention Grant
- Patent Title: Recombinant clostridium botulinum neurotoxins
-
Application No.: US14427234Application Date: 2013-10-31
-
Publication No.: US10030238B2Publication Date: 2018-07-24
- Inventor: Aimee Cossins , Matthew Beard , Philip Marks
- Applicant: Ipsen Bioinnovation Ltd.
- Applicant Address: GB Abingdon, Oxfordshire GB Slough, Berkshire
- Assignee: IPSEN BIOINNOVATION LIMITED,IPSEN BIOPHARM LIMITED
- Current Assignee: IPSEN BIOINNOVATION LIMITED,IPSEN BIOPHARM LIMITED
- Current Assignee Address: GB Abingdon, Oxfordshire GB Slough, Berkshire
- Agency: Barnes & Thornburg LLP
- Agent Davdi A. Kelly; Gene J. Yao
- Priority: GB1219602.8 20121031
- International Application: PCT/GB2013/052845 WO 20131031
- International Announcement: WO2014/068317 WO 20140508
- Main IPC: C12N9/52
- IPC: C12N9/52 ; A61K38/00

Abstract:
The invention provides a nucleic acid sequence comprising a sequence of contiguous nucleotides, wherein said sequence of contiguous nucleotides has at least 90% sequence identity to the nucleic acid sequence of SEQ ID NO: 1, and wherein said sequence of contiguous nucleotides encodes a single-chain BoNT/E1 protein. The present invention also provides methods for producing soluble single-chain BoNT/E1 protein in an E. coli host cell, together with methods for producing soluble di-chain BoNT/E1 protein.
Public/Granted literature
- US20150247139A1 RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS Public/Granted day:2015-09-03
Information query
IPC分类: